Andrew Solomon
Rheumatology · Bothell, WANPI 1588607808
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (55.6%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Bristol Myers Squibb accounts for 67.6% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2019 at $36,460 and has fallen 99.3% since, to $239 in 2022. Among rheumatology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 290 payments — averaging $163.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$32K
- Amgen$11K
- Johnson & Johnson$3K
- Novartis$284
- Lilly USA, LLC$216
- AbbVie$216
- plus $1K from 17 others
What the payments were for
- Consulting fees$8,58818%
- Speaking & faculty fees$26,39156%
- Travel & lodging$7,15515%
- Food & beverage$5,36311%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 51 | $32,092 |
| Amgen(2 entities) | 62 | $10,696 |
| Johnson & Johnson | 47 | $2,519 |
| Novartis | 21 | $284 |
| Lilly USA, LLC | 9 | $216 |
| AbbVie | 12 | $216 |
| GSK | 13 | $213 |
| E.r. Squibb & Sons, L.L.C. | 16 | $202 |
| UCB, Inc. | 5 | $185 |
| Regeneron Healthcare Solutions, Inc. | 4 | $179 |
| Genentech USA, Inc. | 9 | $156 |
| Pfizer | 17 | $135 |
| Radius Health, Inc. | 6 | $106 |
| Mallinckrodt Enterprises LLC | 3 | $65 |
| Sobi, Inc | 3 | $57 |
| Hikma Pharmaceuticals USA | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $30 |
| Sentynl Therapeutics, Inc. | 2 | $28 |
| AstraZeneca | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Sanofi | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
| Janssen Scientific Affairs, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Otezla$40,327
- SIMPONI ARIA$1,856
- KRYSTEXXA$267
- KEVZARA$108
How this compares
$47,498 in reported general payments places this provider in the 90th percentile of 157 rheumatology providers in Washington.
Other rheumatology in Bothell
- Jeff PetersonBothell$2.3M
- Richard JimenezBothell$155K
- Stanford PengSeattle$3.5M
- Philip MeaseSeattle$2.1M
- Robert EttlingerTacoma$232K
- Howard KenneySpokane$132K
- Arinola DadaBellevue$69K
- Verlene GauthierCovington$63K
- Jane BucknerSeattle$57K
- Viviane BuninBellevue$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.